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AbstrAct
Objective: The aim of this study was to review the results of surgery for pediatric patients with 
Cushing’s disease who were less than 18 years old and underwent transsphenoidal surgery in 
a specialized center during a 25-year period. Subjects and methods: Retrospective study, in 
which the medical records, histology and pituitary imaging of 15 consecutive pediatric patients 
with Cushing’s disease (mean age: 13 years) were evaluated by the same team of endocrinolo-
gists and a neurosurgeon from 1982 to 2006. Patients were considered cured when there was 
clinical adrenal insufficiency and serum cortisol levels were below 1.8 μg/dL or 50 nmol/L after 
one, two, three, or seven days following surgery; they therefore required cortisone replacement 
therapy. Follow-up was for a median time of 11.5 years (range: 2 to 25 years). Results: Clinical 
and biochemical cure was achieved in 9/15 patients (60%) exclusively after transsphenoidal 
surgery. Hypopituitarism was observed in four patients; growth hormone deficiency, in two; 
permanent diabetes insipidus, in one case. Conclusions: Cushing’s disease is rare in children 
and adolescents. Transsphenoidal surgery is an effective and safe treatment in most of these 
patients. Plasma cortisol level < 1.8 μg/dL following surgery is the treatment goal and is a good 
predictive factor for long-term cure of Cushing’s disease. Arq Bras Endocrinol Metab. 2010;54(1):17-23
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resumo
Objetivo: O objetivo deste estudo foi avaliar os resultados cirúrgicos em pacientes pediátricos com 
doença de Cushing com idade inferior a 18 anos, submetidos à cirurgia transfenoidal num centro 
especializado, durante um período de acompanhamento de 25 anos. Sujeitos e métodos: Estudo 
retrospectivo dos prontuários médicos de 15 pacientes pediátricos com doença de Cushing (ida-
de média de 13 anos), sendo avaliados aspectos clínicos, laboratoriais, histológicos e radiológicos. 
Todos os pacientes foram avaliados pela mesma equipe de endocrinologistas e operados por um 
mesmo neurocirurgião, entre 1982 e 2006. O tempo médio de seguimento foi 11,5 anos (2 a 25 anos). 
Os pacientes foram considerados curados quando houve insuficiência adrenal e níveis de cortisol 
plasmático inferiores a 1,8 μg/dL ou 50 nmol/L no pós-operatório um, dois, três ou sete dias após a 
cirurgia; estes pacientes necessitaram de reposição de corticosteroide. Resultados: Cura clínica e 
bioquímica foi alcançada em 9/15 pacientes (60%) após a cirurgia transfenoidal. Hipopituitarismo foi 
observado em quatro pacientes; déficit de hormônio de crescimento, em dois; diabetes insípido per-
manente, em um. Conclusões: A doença de Cushing é rara na infância e na adolescência. A cirurgia 
transfenoidal é um tratamento efetivo e seguro para a maioria dos pacientes. Uma concentração de 
cortisol plasmático < 1,8 μg/dL nos primeiros dias pós-cirurgia transfenoidal é o objetivo do tratamen-
to e um fator preditivo tardio para a cura da doença de Cushing. Arq Bras Endocrinol Metab. 2010;54(1):17-23 
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IntroDuctIon
Cushing’s disease (CD) is a life-threatening con-dition in children. It is characterized by hyperse-
cretion of an adrenocorticotropic hormone (ACTH) 
secreting tumor, which causes chronic adrenal overpro-
duction of cortisol (1). The main clinical features and 
some aspects of the management of pediatric patients 
with CD differ somewhat from those seen in adults. 
They include growth impairment, weight gain, hyper-
tension and pubertal delay or arrest. Transsphenoidal 
surgery remains the mainstay of therapy; it allows re-
moval of an ACTH-producing adenoma without the 
need for long-term replacement therapy, though cure 
rates vary (2-6). Surgical technical difficulties and post-
therapy hypopituitarism can be more damaging for 
children than adults because growth and puberty are not 
yet complete (4,7). We report on surgical management 
and outcome of the treatment of 15 pediatric CD pa-
tients, who had only been operated on by the same neu-
rosurgeon over the last 25 years at a specialized center.
subjects AnD methoDs
Patients
This study was approved by the Ethics Committee of 
the Hospital das Clínicas of the Faculdade de Medici-
na de Ribeirão Preto (FMRP) of Universidade de São 
Paulo (USP).
Medical records, imaging findings, and operative 
notes of 15 children younger than 18 years (7 males 
and 8 females), who were admitted consecutively to 
our service with CD from December 1982 to Decem-
ber 2006, were retrospectively reviewed. Patient age 
(mean ± standard deviation, SD) at diagnosis was 13 ± 
2.9 years (range: 6 to 18). The mean duration of CD 
was 3 years (range: 0.5 to 10). The main presenting 
features were weight gain (14/15), impaired growth 
(11/15), and hypertension (10/15). Abdominal striae, 
hirsutism, acne and amenorrhea were observed in 8, 7, 
5 and 3 of the 15 patients, respectively.
All patients were evaluated by a multidisciplinary 
team, in which a neuroendocrinologist, a pediatric endo-
crinologist, and a pediatric neurosurgeon were included. 
Diagnosis of CD was established by suggestive clini-
cal findings, loss of plasma or salivary cortisol circadian 
rhythm and no suppression of cortisol levels after an 
overnight dexamethasone suppression test (20 μg/kg 
up to 1 mg) (8,9). The pituitary etiology of hypercorti-
solism (CD) was determined by measurement of plasma 
ACTH levels, high-dose and very high-dose dexameth-
asone suppression tests in all patients, and the cortico-
trophin releasing hormone (CRH) test (8). All patients 
had some preoperative imaging. Computed tomogra-
phy (CT) was performed in ten patients and magnetic 
resonance (MR), in five cases. Five out of 15 patients 
had normal preoperative imaging; three of them per-
formed CT. Bilateral inferior petrosal sinus sampling 
(BIPSS) for ACTH measure was performed in 2 of the 
15 patients. Diagnosis of CD was confirmed by surgery 
and positive pituitary tissue pathology. Histological 
findings were divided into two groups: (i) obvious pi-
tuitary adenomas with ACTH staining in 12 cases and 
(ii) biopsies with high numbers of ACTH-staining cells 
without evidence of adenoma in 3 patients.
surgical approach and difficulties
All operations were performed by the same neurosur-
geon. The surgical technique and strategy described in 
detail by Hardy, in 1969, was followed (10). Briefly, 
resection of all presumed adenomas was performed via 
a sublabial, paraseptal, transsphenoidal approach. Af-
ter exposition of the sellar region and incision in the 
dura the entire pituitary gland was carefully examined, 
and all abnormal tissue was excised. In patients with 
no clearly abnormal tissue, depending on age, history, 
and severity of disease, hemihypophysectomy, subtotal 
hypophysectomy, or, rarely, total hypophysectomy was 
performed. Aggressiveness of the surgery was individu-
alized, considering patient characteristics, preoperative 
morbidity, severity of clinical symptoms, and recur-
rence of disease.
Fluoroscopy was especially helpful to reduce the risk 
of straying from the midline and injuring the carotid 
artery and cavernous sinus. An airpower drill (Midas 
Rex®, Medtronic Neurological) was used to open the 
sphenoid sinus and reach the pituitary sella in three 
cases, because the sphenoid sinus aeration was absent. 
outcome evaluation
Patients were considered cured when there was clinical 
adrenal insufficiency and serum cortisol levels were < 50 
nmol/L after one, two, three, or seven days following 
surgery; they therefore required cortisone replacement 
therapy. All patients returned to our neuroendocrine 
outpatient clinic at regular intervals for endocrinologi-
cal evaluations. The mean follow-up period was 7.7 
years (range: 2 to 25; median: 3.2).
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results
During the 25-year period, 15 children and adolescents 
with CD were treated with transsphenoidal surgery and 
followed up in the Hospital of Clinics of Ribeirão Pre-
to, University of São Paulo (Table 1).
In this series, imaging correctly localized the ade-
noma within the pituitary fossa in ten patients (66.6%), 
as confirmed by surgery. Eight of the 15 patients had a 
microadenoma; 2 had a macroadenoma; and 5 patients 
were normal in preoperative images. One patient (case 
11) presented with a bilateral microadenoma in preope-
rative MR. Two of the 15 patients (cases 12 and 14) 
underwent BIPSS, which successfully lateralized the le-
sion in both, and surgical cure was achieved after TSS.
In most patients a distinct tumor was visualized 
and excised. Adenomas were found in 12/15 patients 
based on histology (ACTH staining +); 3 patients pre-
sented high numbers of ACTH staining cells (hyper-
plasia) without evidence of adenoma. 
Transsphenoidal excision of the corticotroph adeno-
mas was performed in all patients. Clinical and/or bio-
chemical cure was achieved in nine patients (60%) exclu-
sively after TSS; eight of them achieved both criteria and 
table 1. Surgical management of 15 consecutive pediatric patients with Cushing’s disease
case
no.
Age (yrs)
at surgery/
sex
length of
history
neuroradiological
Features
bIPss Initial 
operative
approach
resec-
tion
histology Post-op 
serum 
cortisol
surgical
cure
complemen-
tary
therapy
rt ADX remission outcome FW
(yrs)
1 12/M 8 mos normal CT NA TSS partial adenoma 
ACTH+
7.2 no 2nd TSS† yes yes yes DM 
hypert
25
2 13/M 1 yr micro (CT) NA TSS‡ total adenoma 
ACTH+
< 1.2 yes NA no no NA normal 23
3 18/F 15 mos micro (CT) NA TSS total adenoma 
ACTH+
< 1.2 yes NA no no NA normal 20
4 12/M 5 yrs normal (CT) NA TSS total adenoma 
ACTH+
7.0 no 2nd TSS 
(Nelson’s 
Syndrome)
yes yes no AP in 
reposition
20
5 14/M 4 yrs normal (CT) NA TSS total adenoma 
ACTH+
< 1.2 yes NA no no NA GH deficit 20
6 15/F 8 mos micro (CT) NA TSS total adenoma 
ACTH+
22.4 no 2nd TSS, 
3rd TSS
(Nelson’s 
Syndrome)
no yes no death§ 3
7 14/F 10 mos micro (CT) NA TSS* total adenoma 
ACTH+, GH+
11.2 no 2nd TSS, 
3rd TSS
(Nelson’s 
Syndrome)
yes yes no ketoconazole 15
8 12/F 3 yrs macro (CT)
CS invasion
NA TSS partial adenoma 
ACTH+
4.2 no NA yes no yes AP in 
reposition
15
9 6/F 2.5 yrs micro (CT) NA TSS* total adenoma 
ACTH+
< 1.2 yes NA no no NA normal 10
10 16/F 6 mos macro (CT)
CS invasion
NA TSS total adenoma 
ACTH+
< 1.2 yes NA no no NA AP in 
reposition, 
DDAVP
9
11 11/F 5 yrs bilateral  
micro (RM)
NA TSS total hyperplasia, 
ACTH+
< 1.2 yes NA no no NA normal 4
12 9/M 1 yr normal (RM) + (R) TSS total hyperplasia, 
ACTH+
< 1.2 yes NA no no NA normal 4
13 13/M 4 yrs micro (RM) NA TSS total adenoma 
ACTH+
< 1.2 yes NA no no NA normal 3
14 15/M 6 yrs normal (RM) + (L) TSS* total hyperplasia, 
ACTH+
2.7 no NA no no yes normal 2
15 16/F 10 yrs micro (RM) NA TSS total adenoma 
ACTH+
4.8 no NA no no no ketoconazole 1
M: male; F: female; CT: computed tomography; MR: magnetic resonance; TSS: transsphenoidal surgery; RT: radiotherapy; ADX: adrenalectomy; FW: follow-up; NA: not applicable; L: left-side gradient; 
R: right-side gradient; BIPSS: bilateral inferior petrosal sinus; Hyper: hypertension; DM: diabetes mellitus; Micro: microadenoma; Macro: macroadenoma; AP: anterior hypopituitarism; GH: growth 
hormone; CS: cavernous sinus.
† Hemorrhage secondary to an anomaly in the venous sinus during sella dissection; ‡ Bleeding during the surgical approach; § Meningitis three years after the 3rd TSS.
* Absence of sphenoid sinus aeration.
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one presented only clinical remission (case 14). It is im-
portant to point out that case number 14 presented postop-
erative plasma cortisol levels of 2.7 μg/dL. All other patients 
presented clinical and biochemical cure after TSS and 
complementary treatment. As this series of patients has 
been collected in a long period of time (24 years), during 
which there have been several improvements in diagnosis, 
surgical and radiotherapic techniques, the patients were 
divided into two groups: operated before and after 1998. 
There was a remarkable improvement of percentage of 
surgical cure (37.5% versus 85.7%) in the latter ten years. 
All nine patients have remained cured and have re-
quired no further treatment to date (median follow-up 
period: 12.1 years; range: 2 to 23 years). The six remain-
ing patients had persisted CD, with a cortisol level in ex-
cess of 300 nmol/L. A second TSS was performed in four 
patients. Three of them, who had persistent hypercorti-
solemia, were treated with postoperative external-beam 
direct pituitary irradiation, using a 6-MV linear accelera-
tor, with 45 Gy in 25 fractions over a period of 35 days 
after surgery. Bilateral adrenalectomy was performed in 
four patients (cases 1, 4, 6 and 7). Three patients devel-
oped Nelson’s syndrome and TSS was performed in two 
patients (cases 6 and 7) for the third time. Postoperative 
radiotherapy was performed as the only complementary 
treatment in one patient (case 8) (Figure 1). 
Hypopituitarism was observed in four patients, two 
of them with macroadenoma (case 8 and 10), one pa-
tient (case 4) after radiotherapy to treat Nelson’s syn-
drome, and one patient after TSS (case 5); permanent 
diabetes insipidus was observed in only one patient (case 
10) and two patients developed growth hormone defi-
ciency (case 5 and 14). One patient (case 6) developed 
meningitis after the third TSS and died.
Figure 1. Case 10: (A) Sagittal and coronal (B) contrast-enhanced MR images obtained in an adolescent with Cushing’s disease, demonstrating a macroadenoma 
(asterisk); (C) contrast-enhanced sagittal MR imaging scan of the sella four years after transsphenoidal surgery and radiotherapy, demonstrating no evidence 
of residual tumor. 
DIscussIon
CD is rare in the pediatric age group (6,11,12). The 
disease remains a complex diagnostic challenge in child-
hood, because many of the diagnosis criteria and defini-
tion of cure after transsphenoidal surgery are based on 
results obtained in adults that have been extrapolated to 
the pediatric population (13). In this study, the mean 
prediagnosis duration of symptoms was 36 months – 
approximately half of that reported in adults (14,15). 
This finding was consistent with other reports of pe-
diatric CD and has been attributed to the additional 
symptoms of growth delay and pubertal arrest, which 
prompt earlier medical evaluation (13). Children with 
CD present with obesity, stunted growth, and mental 
and behavioral problems. More than one-third of pa-
tients also have hypertension. The frequencies of the 
symptoms found were similar to those of other pub-
lished series (5,16). Increased cortisol and ACTH lev-
els, absence of diurnal variation, cortisol and ACTH re-
sponse to CRH test, poor suppression of serum cortisol 
levels with a low dose of dexamethasone, and suppres-
sion with a high dose are considered to be key evidence 
for biochemical diagnosis of CD (11,17). 
CD is often due to microadenomas that may not be 
detectable in routine contrast-enhanced CT and MR 
images. The correct detection rate of corticotroph ad-
enoma for pediatric CD ranges from 52% to 75% for 
CT and/or MR scans in the literature (5). Most of the 
corticotrophin adenomas are small (< 4 mm), and their 
images have similar intensity to those of normal pitu-
itary tissue, making accurate identification of the tumor 
site difficult (18,19). Five out of these 15 patients had 
normal preoperative imaging; 3 of them performed only 
A b c
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CT, previously MR availability. Recently, BIPSS was 
performed successfully in two patients with normal MR 
scan. This procedure proved to be a reliable method of 
tumor localization when CT or MR were normal, as also 
found by other researchers who have reported accuracy 
ranges of 71% to 83% for BIPSS lateralization (5,14,16). 
Transsphenoidal surgery is a safe and effective first-
choice treatment for the management of CD (4-6,20); 
it was the preferred approach for excising the adeno-
ma in the series of the present study. However, some 
peculiarities are observed in the pediatric population. 
Since children have smaller nasal apertures, the subla-
bial route provided a wider corridor to access the sellar 
region than the direct transnasal rhinoseptal approach; 
this allowed the researchers to use the same nasal specu-
lums utilized in adult patients (4). Care should be taken 
not to open the blades of Hardy’s nasal speculum too 
wide within the sphenoid sinus, because the chances 
of injuring the carotid artery are greater in children, 
due to the thin surrounding bones and the narrower 
sphenoid sinus (10). During sellar dural opening, es-
pecially in microadenomas, care should be taken not 
to injure the intercavernous sinuses at the anterior and 
posterior sellar dural limits or the cavernous sinuses lat-
erally, because this may cause excessive venous bleeding 
(13). In two cases, severe hemorrhage was observed – 
which was secondary to an anomaly of the venous sinus 
observed during sella dissection in one case. In more 
table 2. Overview of previously reports on the surgical outcome of the TSS in pediatric Cushing’s disease
series number of cases surgical cure (%) recurrence reoperation remission mortality Follow-up 
Styner and cols. (11) 15 14 (93.3) 0 2 1 0 3.6 years (10 months-8.2 years)
Buchfelder and Falbusch (21) 15 13 (86.6) 0 0 1 1 3.1 years (1.2-11 years)
Haddad and cols. (23) 5 5 (100) 0 0 0 0 4.6 years (0.5 to 9 years)
Partington and cols. (27) 15 12 (80)a 3 0 3 0 4.5 years (0 to 13.5 years)
Magiakou and cols. (6) 37b 35 (94.5) 2 2 2 2  22 months (5 to 60 months) 
Dyer and cols. (22) 36 23 (64) 5 5 5 1 6 months to 21 years
Weber and cols. (12) 9 5 (55.5) 0 0 1 0 1.6 to 10.7 years
Mathivon and cols. (25) 16 9 (56.2) 5 2 3 0 40 ± 35 months
Devoe and cols. (20) 26 19 (73) 7 6 5 0 7.2 years (1.5 to 13.6 years)
Massoud and cols. (24) 12 9 (75) 3 3 2 0 6.8 (1 to 14 years)
Joshi and cols. (5) 25 14 (56) 10 0 11 0 6.9 years (1.3 to 12 years)
Kanter and cols. (13) 33c 22 (66.6) 3 3 8 0 3.6 years (0 to 9 years)
Storr and cols. (28) 27 16 (59) 0 0 0 0 7.1 ± 5.3 years (0.5 to 17.8 years)
Mehrazin (26) 8 6 (75) 2 2 0 0 13.4 (1 to 23 years)
Das and cols. (4) 10 4 (40) 6 1 3 0 5.3 years (1 to 10 years)
Current series 15 8 (53.3) 2 4 2 1 11 years (1 to 25 years)
a In the group of 12 patients with initial remission, 3 patients had a late recurrence; b excluded cases operated on in another service; c ten patients were submitted on TSS surgery in another service4. 
recent cases, the endonasal route and neuronavigation 
have been employed with success.
In this series, even when a tumor was identified 
during surgery, surgical cure was not achieved in all 
patients. The surgical cure rate over 25-year period 
of this study was 60%. However, there was a remark-
able improvement of surgical cure (85.7%) in the lat-
ter ten years. In the literature, surgical cure rates range 
from 40% to 100% (mean: 70.5%), according to table 2 
(4-6,12,13,20-28). In the present study, plasma cor-
tisol levels considered were < 1.8 μg/dL during the 
first days after surgery for cure definition – this is a very 
strict criterion. Notably, the criteria for cure vary sig-
nificantly in the studies from the last 25 years, justifying 
the variable surgical cure rates observed (29,30). In ad-
dition, the experience of the neurosurgeon is another 
important factor. Finally, there have been several im-
provements in surgical techniques, such as endoscopy 
and neuronavigation. All these aspects have improved 
surgical treatment of the CD, but also have rendered 
very difficult to compare patients operated 20 years ago 
with those operated more recently. 
Although recurrence was not observed in this series, 
it could be due to satellite lesions (4,16) adjacent to 
the main tumor. It is now often to proceed to a hemi-
hypophysectomy, ensuring that an adequate normal 
gland is retained. Three patients showed hyperplasia 
of corticotroph cells, but no adenoma in the morpho-
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logic study. Among then, one patient did not achieved 
cure. The others have been cured in a follow-up period 
of four years. Pituitary hyperplasia can be defined as a 
non-neoplastic increase in one or more functionally dis-
tinct types of pituitary cells (31). Kovacs and cols. (32) 
reported a patient who present corticotroph hyper-
plasia and had a long-lasting remission (14 years), but 
CD recurred. The authors suggest that corticotroph 
hyperplasia may cause CD and the elimination of the 
negative inhibitory feedback effect by corticosteroids 
after adrenalectomy plays a role in adenoma initiation 
(32). Therefore, ultimate outcome analysis is critically 
dependent on the criteria adopted to define cure and 
may only be made with careful and long-term follow-
up. Despite a clear need for uniformity in the definition 
of postoperative cure in CD, there is still considerable 
variation in definitions between centers, making mean-
ingful comparison of data difficult (33,34).
As advocated by Trainer and cols. (19), a postop-
erative cortisol level of < 1.8 μg/dL or 50 nmol/L has 
been adopted as criterion of cure, based on the physi-
ological principle that high cortisol levels will suppress 
normal corticotroph function, so that complete remov-
al of a corticotroph adenoma will render the patient 
ACTH deficient, with low or undetectable cortisol lev-
els. Some authors (34) have proposed that the presence 
of an intrasellar lesion and postoperative serum cortisol 
< 50 nmol/L are good predictors of cure in long term, 
with some degree of hypopituitarism. However, Yap 
and cols. (35) concluded that undetectable postopera-
tive cortisol is not always predictive of long-term cure 
in an adult series.
Pituitary radiotherapy is effective for the treatment 
of CD, but it is only used on patients with persisting 
disease after surgery; growth hormone deficiency seems 
to be an unavoidable complication after treatment with 
radiotherapy (5,36). In this series, radiotherapy was per-
formed as complementary treatment in four patients af-
ter TSS, with two of them achieving cure of CD. Recent-
ly, it has been reported that high-precision stereotactic 
radiosurgery (37) and gamma knife surgery (38) can ef-
fectively treat persistent or recurrent CD following TSS.
Bilateral adrenalectomy has long been considered 
the treatment of choice for CD in childhood. Nowa-
days, it still has a role, but should be reserved for pa-
tients in whom surgery and radiotherapy fail to stop 
the secretion of ACTH from the pituitary adenoma 
(25). Although adrenalectomy is the only treatment 
that offers an immediate control of hypercortisolism 
with 100% certainty, it is necessary to consider its side 
effects, including potential adrenal insufficiency crisis. 
Therefore, lifelong need for glucocorticoid and min-
eralocorticoid replacement therapy hyperpigmentation, 
elevated ACTH levels, and an enlarged sella turcica at-
tributable to Nelson’s syndrome have been described 
in 12 to 67% of cases (38-41). In addition, there is a 
continued need for glucocorticoid and mineralocorti-
coid replacement therapy. Bilateral adrenalectomy was 
performed in four patients; three of them developed 
Nelson’s syndrome and were treated with further sur-
gery and radiotherapy. Pituitary radiotherapy at the 
time of adrenalectomy seems to reduce the risk of Nel-
son’s syndrome development (41). 
In conclusion, TSS remains a safe and effective pri-
mary treatment of pediatric CD, with minimal morbid-
ity and mortality and with a cure rate comparable to 
those reported in published series. However, interpre-
tation of the results of surgery depends on the criteria 
adopted to define postoperative cure. Our data support 
the proposals of others that the goal of surgery for CD 
should be to render postoperative cortisol levels low or 
undetectable, while maintaining normal pituitary func-
tion. A neurosurgeon, who is a specialist in pituitary 
disease, is indicated.
Disclosure: no potential conflict of interest relevant to this article 
was reported. 
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